These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8793910)

  • 1. Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret.
    Lehmann A; Kärrberg L
    Neuropharmacology; 1996 Apr; 35(4):475-81. PubMed ID: 8793910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
    Popik P; Kozela E; Danysz W
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
    Hao JX; Xu XJ
    Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX.
    Fink-Jensen A; Judge ME; Hansen JB; Jacobsen P; Turski L; Olney J; Honoré T
    Neurosci Lett; 1992 Mar; 137(2):173-7. PubMed ID: 1350077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
    Zakharova ES; Danysz W; Bespalov AY
    Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret.
    Rudd JA; Naylor RJ
    Neuropharmacology; 1994 Dec; 33(12):1607-8. PubMed ID: 7760983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiemetic activity of granisetron against cytostatic-treatment-induced emesis in 10- to 13-week-old ferrets.
    Marr HE; Davey PT; Boyle EA; Blower PR
    J Cancer Res Clin Oncol; 1994; 120(4):204-7. PubMed ID: 8288674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
    Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
    Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
    Yoshida N; Omoya H; Ito T
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies of the antiemetic activity of granisetron against whole body X-irradiation or cisplatin-induced emesis in the ferret.
    Marr HE; Davey PT; Boyle EA; Blower PR
    Pharmacology; 1994 May; 48(5):283-92. PubMed ID: 8016189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
    Kozela E; Pilc A; Popik P
    Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the reflex responses to distension of the rat urinary bladder.
    Castroman PJ; Ness TJ
    Anesthesiology; 2002 Jun; 96(6):1401-9. PubMed ID: 12170053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of different antiemetic agents on morphine-induced emesis in ferrets.
    Wynn RL; Essien E; Thut PD
    Eur J Pharmacol; 1993 Sep; 241(1):47-54. PubMed ID: 8223924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain.
    Morel V; Pickering G; Etienne M; Dupuis A; Privat AM; Chalus M; Eschalier A; Daulhac L
    Fundam Clin Pharmacol; 2014 Dec; 28(6):671-80. PubMed ID: 24702319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
    Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
    Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-induced emesis in the cat: effect of granisetron and dexamethasone.
    Rudd JA; Tse JY; Wai MK
    Eur J Pharmacol; 2000 Mar; 391(1-2):145-50. PubMed ID: 10720646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.
    Thompson PI; Bingham S; Andrews PL; Patel N; Joel SP; Slevin ML
    Br J Pharmacol; 1992 May; 106(1):3-8. PubMed ID: 1324067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of N-methyl-D-aspartate antagonists on different measures of motion sickness in cats.
    Lucot JB
    Brain Res Bull; 1998 Nov; 47(5):407-11. PubMed ID: 10052568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice.
    Furuya Y; Kagaya T; Ogura H; Nishizawa Y
    Eur J Pharmacol; 1999 Jan; 364(2-3):133-40. PubMed ID: 9932715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
    J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.